
Lionise Pharmaceuticals Private Limited
About Lionise Pharmaceuticals Private Limited
Data last updated:
Lionise Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the fine chemicals and other chemical products segment of the chemicals sector. It was incorporated on 05 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24299DL2019PTC353434. Its GSTIN is 10AAECL0006E1ZK (Bihar).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Avnish Kumar and Rupak Kumar.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 651 4th Floor Aggarwal Chambers – III 26 Veer Sarvarkar Block Shakarpur, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2021, the company reported a revenue of ₹7.09 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹38,890 (net margin -5.5%) and EBITDA of -₹32,671 (EBITDA margin -4.6%).
Company details
Contact details
Lionise Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered Address651 4th Floor Aggarwal Chambers – III 26 Veer Sarvarkar Block Shakarpur, New Delhi, Delhi, India – 110092
- IndustryChemicals, Fine Chemicals And Other Chemical Products, Manufacturing, Other Chemical Product
To see the full contact details of Lionise Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lionise Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Lionise Pharmaceuticals Private Limited, buy the company report.
Financials of Lionise Pharmaceuticals Private Limited
FY 2021 filings availableLionise Pharmaceuticals Private Limited reported revenue of ₹7.09 Lakh (up 450% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue rose 450% in the latest year. EBITDA rose 85% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹32,671 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹38,890 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -4.6% | |
| Net Profit Margin | -5.5% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Lionise Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lionise Pharmaceuticals Private Limited
Lionise Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Avnish Kumar | Director | 05 Aug 2019 | 7 Years 3 Months | Current |
| Rupak Kumar | Director | 05 Aug 2019 | 7 Years 3 Months | Current |
| Deepak Kumar Also directs: Maghra Real Estate Private Limited | Director | 05 Aug 2019 | 7 Years 3 Months | Current |
Peer comparison
Lionise Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gundicha Pharmaceuticals Private Limited | ₹7.09 Lakh (FY 2020) | -7.0% | Mumbai, Maharashtra, India | |||
| Lionise Pharmaceuticals Private Limitedthis company | ₹7.09 Lakh (FY 2021) | -₹38,890 | -5.5% | 450.0% | New Delhi, Delhi, India | |
| Welsave Pharmaceuticals Private Limited | ₹7.07 Lakh (FY 2025) | 70.0% | Delhi, India | |||
| Cradel Pharmaceuticals Pvt Ltd | ₹7.07 Lakh (FY 2025) | 15.0% | Pailan Hut, West Bengal, India |
To see the full peer comparison of Lionise Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lionise Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lionise Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lionise Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAECL0006E1ZK | Bihar | Active | 15 Aug 2019 |
To see the full GST registrations and return filing status of Lionise Pharmaceuticals Private Limited, buy the company report.
Recent activity
Lionise Pharmaceuticals Private Limited has 3 board changes on record since 2019: 3 appointments. The latest: Avnish Kumar was appointed as Director on 05 Aug 2019.
Frequently asked questions
Lionise Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in fine chemicals and other chemical products, within the chemicals industry. It was incorporated on 05 August 2019 (7+ years old) and is registered under CIN U24299DL2019PTC353434.
Lionise Pharmaceuticals has 3 current directors:
- Avnish Kumar - Director
- Rupak Kumar - Director
- Deepak Kumar - Director
The latest financial statements of Lionise Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Lionise Pharmaceuticals is 10AAECL0006E1ZK, registered in Bihar.
The CIN (Corporate Identification Number) of Lionise Pharmaceuticals is U24299DL2019PTC353434. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lionise Pharmaceuticals was incorporated on 05 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Lionise Pharmaceuticals by revenue are Gundicha Pharmaceuticals Private Limited, Welsave Pharmaceuticals Private Limited, Cradel Pharmaceuticals Pvt Ltd, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Avnish Kumar was appointed as Director on 05 Aug 2019. Deepak Kumar was appointed as Director on 05 Aug 2019. Rupak Kumar was appointed as Director on 05 Aug 2019.
The registered office of Lionise Pharmaceuticals is at 651 4th Floor Aggarwal Chambers – III 26 Veer Sarvarkar Block Shakarpur, New Delhi, Delhi, India – 110092.
Lionise Pharmaceuticals operates in the chemicals industry, in the fine chemicals and other chemical products segment.
Lionise Pharmaceuticals can be reached at its registered office: 651 4th Floor Aggarwal Chambers – III 26 Veer Sarvarkar Block Shakarpur, New Delhi, Delhi, India – 110092.

